Draupnir Bio

0 followers


Draupnir Bio intends to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company is developing a platform for exploring the glycome to develop novel therapeutics, based on array technology, protein chemistry, a... Read more

Industries

+2

Headquarters

Employees

Links

Org chart

Andrew Hotchkiss
Chief Executive Officer

Andrew Hotchkiss

Collapse
Casper Tind Hansen
Chief Business Officer
Joachim Pold Vilstrup
Co-founder Of Draupnir Bio
Simon Feldbæk Nielsen
Chief Technology Officer (Head of R&D)